SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-006908
Filing Date
2016-07-13
Accepted
2016-07-12 17:46:20
Documents
33
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-053116.htm 10-Q 224097
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31.1 8991
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31.2 8979
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32.1 4919
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32.2 4984
  Complete submission text file 0001019687-16-006908.txt   947841

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20160331.xml EX-101.INS 75587
7 XBRL SCHEMA FILE cnbx-20160331.xsd EX-101.SCH 12614
8 XBRL CALCULATION FILE cnbx-20160331_cal.xml EX-101.CAL 27415
9 XBRL DEFINITION FILE cnbx-20160331_def.xml EX-101.DEF 15463
10 XBRL LABEL FILE cnbx-20160331_lab.xml EX-101.LAB 90773
11 XBRL PRESENTATION FILE cnbx-20160331_pre.xml EX-101.PRE 64452
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 161764611
SIC: 1000 Metal Mining